Bnp Paribas Asset Management Holding S.A. Gilead Sciences, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

$37.6 Billion
Q1 2024

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 666,337 shares of GILD stock, worth $45.7 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

666,337

Previous 1,363,637 51.14%

Holding current value

$45.7 Million

Previous $110 Million 55.82%

% of portfolio

0.13%

Previous 0.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $49.9 Million - $60.9 Million	-697,300 Reduced 51.14%	666,337 $48.8 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $28.2 Million - $31.9 Million	384,516 Added 39.27%	1,363,637 $110 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $1.73 Million - $1.89 Million	23,412 Added 2.45%	979,121 $73.4 Million
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $9.6 Million - $10.9 Million	-126,241 Reduced 11.67%	955,709 $73.7 Million
Q1 2023 May 08, 2023	BUY	$77.31 - $88.08 $12.1 Million - $13.8 Million	156,538 Added 16.92%	1,081,950 $89.8 Million

Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $44.7 Million - $64.2 Million	-717,705 Reduced 43.68%	925,412 $79.4 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $511,924 - $584,749	8,598 Added 0.53%	1,643,117 $101 Million
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $89,639 - $100,960	-1,553 Reduced 0.09%	1,634,519 $101 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $14.9 Million - $18.7 Million	257,337 Added 18.66%	1,636,072 $97.3 Million
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $21.7 Million - $24.6 Million	-334,360 Reduced 19.52%	1,378,735 $100 Million
Q3 2021 Nov 08, 2021	SELL	$67.69 - $73.03 $21.1 Million - $22.8 Million	-311,819 Reduced 15.4%	1,713,095 $120 Million
Q2 2021 Aug 05, 2021	BUY	$63.47 - $69.35 $20.6 Million - $22.5 Million	324,369 Added 19.07%	2,024,914 $139 Million
Q1 2021 May 05, 2021	BUY	$60.0 - $68.46 $4.42 Million - $5.05 Million	73,748 Added 4.53%	1,700,545 $110 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $6.31 Million - $7.2 Million	-111,468 Reduced 6.41%	1,626,797 $94.8 Million
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $26.4 Million - $33.1 Million	424,539 Added 32.32%	1,738,265 $110 Million
Q2 2020 Aug 04, 2020	BUY	$72.34 - $84.0 $31 Million - $36 Million	428,556 Added 48.42%	1,313,726 $101 Million
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $10.4 Million - $13.3 Million	165,533 Added 23.0%	885,170 $66.2 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $3.5 Million - $3.85 Million	56,842 Added 8.58%	719,637 $46.8 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $12.1 Million - $13.3 Million	-193,184 Reduced 22.57%	662,795 $42 Million
Q2 2019 Aug 02, 2019	SELL	$61.87 - $69.38 $2.07 Million - $2.33 Million	-33,531 Reduced 3.77%	855,979 $57.8 Million
Q1 2019 Apr 26, 2019	SELL	$62.53 - $70.05 $1.64 Million - $1.84 Million	-26,277 Reduced 2.87%	889,510 $57.8 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $4.37 Million - $5.7 Million	-72,182 Reduced 7.31%	915,787 $56.7 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $8.83 Million - $9.77 Million	-123,842 Reduced 11.14%	987,969 $76.3 Million
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $16.2 Million - $18.9 Million	250,160 Added 29.03%	1,111,811 $78.8 Million
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $38.6 Million - $47.1 Million	530,464 Added 160.17%	861,651 $65 Million
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $11.9 Million - $14 Million	167,048 Added 101.77%	331,187 $23.7 Million
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $11.8 Million - $14 Million	164,139	164,139 $13.3 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Gilead Sciences, Inc. Transaction History